Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2880 of 5804
-
Can sinus surgery help cystic fibrosis lungs? new study investigates
Knowledge-focused Recruiting nowThis study will be a prospective, observational study of patients who undergo endoscopic sinus surgery for cystic fibrosis-related chronic rhinosinusitis (CRS). Individuals who do not undergo surgery but are treated medically for CRS will also be enrolled to serve as a control gr…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New research platform aims to unlock secrets of brain metastases
Knowledge-focused Recruiting nowDespite some encouraging data, systemic treatment of CNS metastases from solid tumors remains experimental. Better knowledge on the evolving epidemiology and biology of BM are key elements for the development of new treatment strategies and identification of promising therapeuti…
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New recovery plan may get kids home faster after bowel surgery
Symptom relief CompletedThe institution of perioperative Enhanced Recovery Protocols (ERPs) has been found to decrease hospital length of stay, in-hospital costs, and complications among adult surgical populations but data in pediatric populations are lacking. The Assessing Effectiveness and Implementat…
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Could a Two-Drug sequence shrink tumors with fewer side effects?
Disease control OngoingThis phase I trial studies the side effects and best dose of adavosertib when given together with olaparib in treating patients with solid tumors that have spread to other places in the body (advanced) with selected mutations. Adavosertib may stop the growth of tumor cells by blo…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
UV water treatment tested to keep kids healthy
Prevention CompletedApproximately 40 million people in the US are served by private wells, many of which are untreated. The investigators estimate that 1.29 million cases of gastrointestinal illness (GI) per year are attributed to consuming water from untreated private wells in the US. These cases o…
Phase: NA • Sponsor: Temple University • Aim: Prevention
Last updated Jun 26, 2026 14:41 UTC
-
Experimental drug shows promise in slowing duchenne muscle loss
Disease control OngoingThis is a multicenter, open-label, long-term, extension, phase 2 study to evaluate the safety and efficacy of long-term treatment with DS-5141b in patients with DMD who have completed DS5141-A-J101.
Phase: PHASE2 • Sponsor: Daiichi Sankyo Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:48 UTC
-
New drug combo takes on Hard-to-Treat bone marrow cancer
Disease control Recruiting nowThis study will determine the safety profile, maximum tolerated dose (MTD), dose-limiting toxicities (DLT), and recommended Phase 2 dose (RP2D) of SX-682 in the treatment of patients with Myelodysplastic Syndromes (MDS).
Phase: PHASE1 • Sponsor: Syntrix Biosystems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New device could let surgeons see tissues in real time during gynecological surgery
Diagnosis Recruiting nowOptical biopsy is a new technology that generates a real-time, cell-based, high-resolution view and analysis of tissues. Observation is instantaneous and non-invasive. This allows reliable and fast diagnosis which facilitates decision making as well as patient management. The in…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Coffee-Inspired cream may protect breast cancer patients from radiation damage
Symptom relief OngoingThe purpose of the study is to evaluate whether a caffeine-based cream can reduce the rates of reconstructive complications in patients with tissue expander based reconstruction requiring post-mastectomy radiation therapy when compared to a placebo cream.
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New scaffold may help older patients heal torn shoulder tendons
Disease control CompletedRandomized controlled trial of patients over the age of 55 treated with and without a nanofiber scaffold during rotator cuff repair.
Phase: NA • Sponsor: Atreon Orthopedics • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New stent device aims to fix Hard-to-Treat aortic aneurysms
Disease control OngoingProspective, multi-center, non-randomized study with consecutive, eligible subject enrollment at each site, for the evaluation of the ChEVAS System for Endovascular Repair of Complex Abdominal Aortic Aneurysms.
Phase: NA • Sponsor: Endologix • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can two drugs reboot radioiodine therapy for tough thyroid cancers?
Disease control CompletedThe purpose of this study is to develop a new drug treatment to reverse tumor resistance to radioiodine in BRAF mutant tumors so that radioiodine can be given to shrink tumors. This study is also being done to find out the highest doses of copanlisib and vemurafenib that, when gi…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 14:34 UTC
-
New drug combo takes aim at Hard-to-Treat cancers
Disease control Recruiting nowPhase 1, open-label dose-escalation study to determine the MTD of INV-1120 and RP2D, and to assess the DLT of INV-1120 as a single agent or in the combination with pembrolizumab. The safety, tolerability, and PK of INV-1120 as a single agent or in the combination with pembrolizum…
Phase: PHASE1 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could a common heart drug tame nosebleeds in rare disease?
Symptom relief TerminatedHereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder of angiogenesis associated with disabling epistaxis. Management of these nose bleedings requires more effective treatment. Propranolol, a beta-blocker, is a potentially useful therapeutic considering its anti-angio…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Experimental combo shows promise for tough bile duct cancer
Disease control TerminatedThe purpose of this research study is to determine the safety and efficacy of CPI-613 (devimistat) in the treatment of advanced biliary tract cancer when used in combination with standard of care chemotherapy (gemcitabine plus cisplatin) compared to gemcitabine plus cisplatin alo…
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New registry tracks artificial sphincter success for female incontinence
Disease control CompletedProspective collection of pre-defined parameters of AUS Surgery for Female Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency
Sponsor: European Association of Urology Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Why kidney disease drains your strength: scientists probe muscle fatigue
Knowledge-focused TerminatedChronic Kidney Disease (CKD) induces many metabolic troubles especially for the advanced CKD (stage 3b-5) patients and their prevalence and importance grow with the deterioration of the glomerular filtration rate (GFR). Among them, muscle wasting is common and multifactorial, par…
Phase: NA • Sponsor: Centre Hospitalier le Mans • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Sound waves zapped brain to kill cancer pain – tiny study shows promise
Symptom relief CompletedThis proposed pilot study will investigate the safety and initial effectiveness of focused ultrasound lesioning of the contralateral mesencephalon for severe, opioid-resistant pain associated with head and neck cancer
Phase: NA • Sponsor: Jeff Elias, MD • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Mini device implanted in prostate tumors could reveal best drug match
Knowledge-focused ENROLLING_BY_INVITATIONIn this research study, is assessing the feasibility of using an MR-guided implantable microdevice to measure tumor response to chemotherapy and other clinically relevant drugs in participants that have prostate cancer and are scheduled for a radical prostatectomy. The name of t…
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Could a tiny implant shield the rectum from radiation damage?
Disease control CompletedAssessment of efficacy and safety of implantable spacers when used to reduce the radiation dose delivered to the organs at risk in prostate cancer patients undergoing radiotherapy.
Sponsor: BioProtect • Aim: Disease control
Last updated Jun 26, 2026 17:55 UTC